斯托克治疗

US · STOK #2942 按市值排名上市于 2019

24.17 -0.44 -1.79%

实时 - 追踪5344个代码 - 心跳于194秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了1家。
机构持股总比例下降了7.8个百分点。

机构持股

机构持股比例: 120.73% -7.76pp
机构数量: 240 -1
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund68.99%

Hedge Fund34.35%

Public Company11.62%

VC/PE Fund4.21%

Individual/Insider3.71%

Private Company0.78%

Government Pension Fund0.39%

Sovereign Wealth Fund0.26%

主要股东截至 2026-06-30

BlackRock 9.11% · 5.88M 股

RTW Investments, LP 8.72% · 5.62M 股

FMR 8.23% · 5.31M 股

T. Rowe Price Group, Inc. 7.87% · 5.08M 股

Lynx1 Capital Management LP 6.26% · 4.04M 股

Redmile Group, LLC 6.12% · 3.95M 股

BVF Partners L.P. 5.59% · 3.61M 股

Wellington Management Group 5.45% · 3.52M 股

Morgan Stanley 5.31% · 3.43M 股

Baker Bros. Advisors LP 5.17% · 3.34M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 25次买入 · 25次卖出

姓名	职务	持股比例
Seth Harrison	Independent Chairperson	2.91%
Adrian Krainer	Co-Founder & Independent Director	0.44%
Edward Kaye	Chief Executive Officer	0.19%
Arthur Tzianabos	Independent Director	0.05%
Arthur Levin	Independent Director	0.03%
Jonathan Allan	Corporate Secretary & General Counsel	0.03%
Barry Ticho	Chief Medical Officer	0.03%
Jason Hoitt	Chief Commercial Officer	0.02%
Thomas Edward Leggett	Chief Financial Officer	0.02%
Ian Smith	Director	--

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-10-01	Jonathan Allan	Corporate Secretary & General Counsel	Automatic Disposition	-627	$26.33
2026-09-30	Barry Ticho	Chief Medical Officer	Automatic Disposition	-1,051	$26.16
2026-09-22	Alexander Cumbo	Director	Other Derivative Acquisition	+39,674	$26.11
2026-08-31	Barry Ticho	Chief Medical Officer	Automatic Disposition	-5,545	$30.51–31.06
2026-08-17	Edward Kaye	Chief Executive Officer	Derivative Exercise and Sale	-12,567	$32.01–32.47
2026-08-17	Barry Ticho	Chief Medical Officer	Derivative Exercise and Sale	-4,767	$32.01–32.47
2026-08-17	Jonathan Allan	Corporate Secretary & General Counsel	Derivative Exercise and Sale	-2,861	$32.01–32.47
2026-08-13	Edward Kaye	Chief Executive Officer	Derivative Exercise and Retained	+13,683	--
2026-08-13	Barry Ticho	Chief Medical Officer	Derivative Exercise and Retained	+5,233	--
2026-08-13	Jonathan Allan	Corporate Secretary & General Counsel	Derivative Exercise and Retained	+3,139	--
2026-08-02	Barry Ticho	Chief Medical Officer	Automatic Disposition	-7,176	$28.95–29.45
2026-07-15	Seth Harrison	Independent Chairperson	Other Derivative Acquisition	+151,595	$10.90–40.37
2026-07-15	Seth Harrison	Independent Chairperson	Other Derivative Disposition	-151,595	$10.90–40.37
2026-07-14	Thomas McCauley	Chief Scientific Officer	Other Derivative Acquisition	+225,000	$29.91
2026-06-30	Barry Ticho	Chief Medical Officer	Automatic Disposition	-7,228	$32.62–33.27
2026-06-15	Jonathan Allan	Corporate Secretary & General Counsel	Automatic Disposition	-1,457	$29.95
2026-06-02	Seth Harrison	Independent Chairperson	Other Derivative Acquisition	+17,786	$29.46
2026-06-02	Arthur Levin	Independent Director	Other Derivative Acquisition	+17,786	$29.46
2026-06-02	Julie Smith	Independent Director	Other Derivative Acquisition	+17,786	$29.46
2026-06-02	Jennifer Burstein	Independent Director	Other Derivative Acquisition	+17,786	$29.46

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。